Table 2.
Cox regression analyses of the various factors associated with PFS and OS in NPC patients
Variables | progression-free survival | overall survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Gender (Female/Male) | 0.546 | 0.248-1.200 | 0.132 | 0.492 | 0.221-1.096 | 0.083 |
Age(≤48/>48) | 0.710 | 0.380-1.327 | 0.283 | 0.595 | 0.316-1.120 | 0.108 |
Stage(I+II/III+IV) | 2.430 | 0.810-7.289 | 0.113 | 2.466 | 0.868-7.003 | 0.090 |
Metastasis No metastasis |
0.529 | 0.169-1.655 | 0.274 | 0.476 | 0.162-1.400 | 0.178 |
CALR(High/Low) | 2.564 | 1.217-5.405 | 0.013 | 3.179 | 1.464-6.902 | 0.003 |
HR, hazard ratio; 95% CI, 95% confidence interval